Pharmaceutical giant Eli Lilly said the change takes effect immediately for people on private insurance, as well as the uninsured. The cap puts the drugmaker in line with a provision in the Inflation Reduction Act, which capped the out-of-pocket cost of insulin at $35 a month for seniors enrolled in Medicare.
The move could prompt other big insulin producers to lower the cost of the notoriously expensive lifesaving medication, experts said.
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
